DevchandPaulDO

PubMed

• Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
  Charles E Geyer Jr, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puha...> ;Journal of Clinical Oncology. 2024 Apr 20
• 8 citations
  Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients
  Devchand Paul, Svetislava J. Vukelja, Frankie A. Holmes, Joanne L. Blum, Kristi McIntyre, Deborah Lindquist, Cynthia Osborne, Ines J. Sanchez, Jerome H. Goldschmidt, Y...> ;NPJ Breast Cancer. 2019 Oct 28
• 8 citations
  Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus‐Associated Stomatitis: A Randomized Phase II Study
  Vicky E. Jones, Kristi McIntyre, Devchand Paul, Sharon Wilks, Sharon M. Ondreyco, Scot Sedlacek, Anton Melnyk, Sanjay P. Oommen, Yunfei Wang, Susan Peck, Joyce O'Shaug...> ;The Oncologist. 2019 Sep 1
• 6 citations
  Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
  Barbara Schwartzberg, Daniel T. Chin, Paige L. Dorn, David S. Herron, Kathryn Howell, Tyler James Kemmis, Stephanie A. Miller, Joyce A. Moore, Devchand Paul> ;American Journal of Surgery. 2018 Oct 1
• 27 citations
  Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Ran...
  Denise A. Yardley, James Reeves, E. Claire Dees, Cynthia R. C. Osborne, Devchand Paul, Foluso O. Ademuyiwa, Hatem Soliman, Troy Guthrie, Jay Andersen, Lea Krekow, Jana...> ;Clinical Breast Cancer. 2016 Dec 1
• 20 citations
  Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors.
  Henry J. Thompson, Scot M. Sedlacek, Pamela Wolfe, Devchand Paul, Susan G. Lakoski, Mary C. Playdon, John N. McGinley, Shawna B. Matthews> ;Nutrients. 2015 Jun 26
• 49 citations
  Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine
  Joyce O'Shaughnessy, Hartmut Koeppen, Yuanyuan Xiao, Mark R. Lackner, Devchand Paul, Christopher Stokoe, John Pippen, Lea Krekow, Frankie A. Holmes, Svetislava J. Vuke...> ;Clinical Cancer Research. 2015 Jun 3
• 11 citations
  Weight loss interventions for breast cancer survivors: impact of dietary pattern.
  Henry J. Thompson, Scot M. Sedlacek, Mary C. Playdon, Pamela Wolfe, John N. McGinley, Devchand Paul, Susan G. Lakoski> ;Plos One. 2015 May 26
• 4 citations
  A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
  Thomas G. Frazier, Kevin Fox, J. Stanley Smith, Christine Laronga, Anita P. McSwain, Devchand Paul, Michael Schultz, Joseph Stilwill, Christine B. Teal, Tracey Weisber...> ;Pharmaceuticals. 2015 Mar 17
• 94 citations
  Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study
  Stephen E. Jones, Rufus P. Collea, Devchand Paul, Scot Sedlacek, Anne Favret, Ira Gore, Deborah Lindquist, Frankie A. Holmes, Mary Ann K Allison, Barry Don Brooks, Rau...> ;The Lancet. Oncology. 2013 Oct 1
• 15 citations
  Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage b...
  J. Pippen, Devchand Paul, Svetislava J. Vukelja, Alicia Clawson, Jose Iglesias> ;Breast Cancer Research and Treatment. 2011 Oct 6
• Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Explo...
  Pippen JE, Paul D, Stokoe CT, Blum JL, Krekow L, Holmes FA, Lindquist DL, Sedlacek SM, Rivera RR, Brooks RJ, Vukelja SJ, McIntyre K, Lopez-Diaz C, O'Shaughnessy J> ;J. Clin. Oncol.. 2011-05-20
• 66 citations
  Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study
  Georgiana K. Ellis, Henry G. Bone, Rowan T. Chlebowski, Devchand Paul, Silvana Spadafora, Michelle Fan, Dennis D. Kim> ;Breast Cancer Research and Treatment. 2009 Mar 24
• 9 citations
  The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
  Cynthia R. C. Osborne, Anita Duncan, Scot Sedlacek, Devchand Paul, Frankie A. Holmes, Svetislava J. Vukelja, Michael Kasper, Sharon Wilks, Andrew B. Schneider, Richard...> ;Breast Cancer Research and Treatment. 2009 Jan 13
• 20 citations
  The Effect of Tamoxifen or Exemestane on Bone Mineral Density During the First 2 Years of Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer
  Stephen E. Jones, Christopher Stokoe, Mark Sborov, Marcus Braun, Sukumar Ethirajan, Leila Kutteh, J. Pippen, Mrugesh Patel, Devchand Paul, Joanne L. Blum, Frankie A. H...> ;Clinical Breast Cancer. 2008 Dec 1
• 332 citations
  Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
  Georgiana K. Ellis, Henry G. Bone, Rowan Chlebowski, Devchand Paul, Silvana Spadafora, Judy Smith, Michelle Fan, Susie Jun> ;Journal of Clinical Oncology. 2008 Oct 20
• Subgroup analysis of a randomized, phase III study of the effect of denosumab in women with nonmetastatic breast cancer receiving aromatase inhibitor (AI) therapy.
  Ellis GK, Bone HG, Chlebowski RT, Paul D, Spadafora S, Smith J, Fan M, Jun S> ;J. Clin. Oncol.. 2008-05-20
• Join now to see all